Ciprofloxacin Therapeutic Use. Long-term carcinogenicity studies in rats and mice resulted in no carcinogenic or tumorigenic effects due to ciprofloxacin at daily oral dose levels up to 250 mgkg and 750 mgkg to rats and mice respectively approximately 17-and 25-times the highest recommended therapeutic dose based upon body surface area respectively. Levofloxacin and ciprofloxacin are also options for acute watery diarrhea single dose 500 mg and 750 mg respectively and febrile diarrheadysentery in areas with high rates of Shigella 500 mg once for 3 days once daily with levofloxacin and twice daily with ciprofloxacin but are becoming less effective because of increasing.
Consideration should be given to official guidance on the appropriate use of antibacterial agents. The most common side effects are low levels of neutrophils a type of white blood cell diarrhea nausea anemia low red blood cell counts nose and throat infection and tiredness. Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy.
Cipro IV See Ciprofloxacin IV.
Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. Ciprofloxacin is used to treat a variety of bacterial infections. Besifloxacin 06 one drop TID x 7 days Ciprofloxacin 03 1-2 drops q2h while awake x 48 hours then 1-2 drops q4h x 5 days Moxifloxacin 05 one drop TID x 7 days Ciprofloxacin 03 1-2 drops q2h while awake x 48 hours then 1-2 drops q4h x 5 days. Therapeutic Drug Substitutions Page 6 Appendix 4.